Geode Capital Management
CLDX icon

Geode Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$34M Buy
1,672,980
+83,174
+5% +$1.69M ﹤0.01% 1642
2025
Q1
$28.9M Buy
1,589,806
+54,890
+4% +$996K ﹤0.01% 1694
2024
Q4
$38.8M Sell
1,534,916
-5,597
-0.4% -$141K ﹤0.01% 1594
2024
Q3
$52.4M Buy
1,540,513
+6,557
+0.4% +$223K ﹤0.01% 1397
2024
Q2
$56.8M Buy
1,533,956
+119,578
+8% +$4.43M 0.01% 1271
2024
Q1
$59.4M Buy
1,414,378
+296,384
+27% +$12.4M 0.01% 1238
2023
Q4
$44.3M Buy
1,117,994
+117,569
+12% +$4.66M ﹤0.01% 1419
2023
Q3
$27.5M Buy
1,000,425
+35,352
+4% +$973K ﹤0.01% 1622
2023
Q2
$32.7M Buy
965,073
+39,365
+4% +$1.34M ﹤0.01% 1526
2023
Q1
$33.3M Buy
925,708
+42,173
+5% +$1.52M ﹤0.01% 1465
2022
Q4
$39.4M Buy
883,535
+30,829
+4% +$1.37M 0.01% 1322
2022
Q3
$24M Buy
852,706
+11,582
+1% +$326K ﹤0.01% 1601
2022
Q2
$22.7M Sell
841,124
-14,389
-2% -$388K ﹤0.01% 1675
2022
Q1
$29.1M Buy
855,513
+45,093
+6% +$1.54M ﹤0.01% 1630
2021
Q4
$31.3M Buy
810,420
+17,913
+2% +$692K ﹤0.01% 1663
2021
Q3
$42.8M Buy
792,507
+119,559
+18% +$6.45M 0.01% 1408
2021
Q2
$22.5M Buy
672,948
+320,251
+91% +$10.7M ﹤0.01% 1888
2021
Q1
$7.27M Buy
352,697
+53,643
+18% +$1.1M ﹤0.01% 2580
2020
Q4
$5.24M Buy
299,054
+41,425
+16% +$726K ﹤0.01% 2579
2020
Q3
$3.82M Buy
257,629
+127,392
+98% +$1.89M ﹤0.01% 2554
2020
Q2
$1.69M Buy
130,237
+26,254
+25% +$341K ﹤0.01% 2928
2020
Q1
$172K Hold
103,983
﹤0.01% 3593
2019
Q4
$231K Buy
103,983
+790
+0.8% +$1.76K ﹤0.01% 3749
2019
Q3
$219K Hold
103,193
﹤0.01% 3733
2019
Q2
$276K Sell
103,193
-5,112
-5% -$13.7K ﹤0.01% 3689
2019
Q1
$532K Sell
108,305
-1,011,608
-90% -$4.97M ﹤0.01% 3418
2018
Q4
$221K Buy
1,119,913
+92,792
+9% +$18.3K ﹤0.01% 3644
2018
Q3
$463K Sell
1,027,121
-6,669
-0.6% -$3.01K ﹤0.01% 3489
2018
Q2
$520K Sell
1,033,790
-90,864
-8% -$45.7K ﹤0.01% 3426
2018
Q1
$2.62M Buy
1,124,654
+18,913
+2% +$44.1K ﹤0.01% 2620
2017
Q4
$3.14M Buy
1,105,741
+148,077
+15% +$420K ﹤0.01% 2496
2017
Q3
$2.74M Buy
957,664
+15,840
+2% +$45.3K ﹤0.01% 2567
2017
Q2
$2.33M Buy
941,824
+58,038
+7% +$143K ﹤0.01% 2646
2017
Q1
$3.19M Buy
883,786
+98,114
+12% +$354K ﹤0.01% 2387
2016
Q4
$2.78M Buy
785,672
+23,103
+3% +$81.8K ﹤0.01% 2442
2016
Q3
$3.08M Buy
762,569
+88,388
+13% +$357K ﹤0.01% 2282
2016
Q2
$2.96M Buy
674,181
+4,594
+0.7% +$20.2K ﹤0.01% 2221
2016
Q1
$2.53K Buy
669,587
+10,982
+2% +$42 ﹤0.01% 2295
2015
Q4
$10.3M Buy
658,605
+22,400
+4% +$351K 0.01% 1360
2015
Q3
$6.71M Sell
636,205
-3,601
-0.6% -$38K ﹤0.01% 1637
2015
Q2
$16.1M Buy
639,806
+32,114
+5% +$810K 0.01% 1074
2015
Q1
$16.9M Buy
607,692
+85,342
+16% +$2.38M 0.01% 1020
2014
Q4
$9.53M Buy
522,350
+13,587
+3% +$248K 0.01% 1373
2014
Q3
$6.59M Buy
508,763
+590
+0.1% +$7.65K ﹤0.01% 1582
2014
Q2
$8.29M Buy
508,173
+2,375
+0.5% +$38.8K 0.01% 1446
2014
Q1
$8.94M Buy
505,798
+48,484
+11% +$857K 0.01% 1334
2013
Q4
$11.1M Buy
457,314
+40,572
+10% +$982K 0.01% 1116
2013
Q3
$14.8M Buy
416,742
+79,277
+23% +$2.81M 0.01% 839
2013
Q2
$5.27M Buy
+337,465
New +$5.27M ﹤0.01% 1385